Repeated oral glucose tolerance tests in women at risk for gestational diabetes mellitus. 2019

L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
Department of Obstetrics & Gynecology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: l.dewit-3@umcutrecht.nl.

OBJECTIVE Pregnant women with a negative oral glucose tolerance test (OGTT) between 24-28 weeks as part of risk-based screening for gestational diabetes mellitus (GDM) may develop clinical signs or symptoms suggestive for GDM in the third trimester. We aimed to determine the additional yield of repeating an OGTT to detect missed GDM in this group and assess patient characteristics and indications associated with a positive second OGTT. METHODS We conducted a retrospective cohort study of women with a negative OGTT between 24-28 weeks of pregnancy in two hospitals in the Netherlands. Patient characteristics, pregnancy outcomes, OGTT results and indications were compared between women with normal (non-GDM) and abnormal (GDM) results of the second OGTT, using the WHO 1999 criteria (fasting glucose ≥7.0 mmol/L or 2 -h post load ≥7.8 mmol/L). We used receiver operating characteristic (ROC) curve analysis to determine cut-offs for fasting and 2 -h glucose values of the index OGTT that were associated with a positive OGTT in the third trimester. RESULTS Of 3147 women at risk for GDM, 183 underwent a second OGTT in the third trimester following their regular OGTT at 24-28 weeks. In 43 women (23.5%) GDM was diagnosed based on the second OGTT. A history of GDM was associated with subsequent GDM diagnosis, with an odds ratio of 2.6 (95% CI 1.0-6.3). Both fasting and 2 -h post load glucose values of the index OGTT were significantly higher in women with abnormal OGTT results later in pregnancy. Index OGTT glucose value cut-offs of 4.8 mmol/L (fasting) and 6.5 mmol/L (2 -h) had positive predictive values of 0.32 and 0.47 for a positive OGTT in the third trimester, and negative predictive values of 0.83 and 0.90, respectively. Fetal growth as a clinical symptom for GDM was the most frequent indication for repeating the OGTT, resulting in the diagnosis of GDM in 22.7% of women tested for this indication. CONCLUSIONS Repeating an OGTT after initial negative screening results in additional GDM diagnoses. In case of clinical signs, especially in women with additional risk factors such as a history of GDM or higher index OGTT glucose values, repeating an OGTT could be considered.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D016640 Diabetes, Gestational Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA. Diabetes Mellitus, Gestational,Diabetes, Pregnancy-Induced,Gestational Diabetes,Diabetes, Pregnancy Induced,Gestational Diabetes Mellitus,Pregnancy-Induced Diabetes

Related Publications

L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
August 2011, Journal of clinical pathology,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
October 2019, Diabetes & metabolism journal,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
October 1999, Ginekologia polska,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
September 2020, Diabetic medicine : a journal of the British Diabetic Association,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
May 2023, Archives of gynecology and obstetrics,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
January 2004, West African journal of medicine,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
November 1991, Diabetes care,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
January 2014, Pakistan journal of medical sciences,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
April 2012, European journal of public health,
L de Wit, and D M Bos, and A P van Rossum, and B B van Rijn, and K E Boers
September 2015, Asia-Pacific journal of public health,
Copied contents to your clipboard!